Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.05
-0.0260-1.25%
Post-market: 2.120.0659+3.21%19:37 EDT
Volume:96.59K
Turnover:199.80K
Market Cap:34.74M
PE:-0.87
High:2.10
Open:2.09
Low:2.03
Close:2.08
Loading ...

NRX Pharmaceuticals Unit Secures $27 Million Funding; Shares Jump

MT Newswires Live
·
29 Jan

NRx Pharmaceuticals invests $27M in subsidiary Hope for clinic acquisitions

TIPRANKS
·
28 Jan

Hope Therapeutics™, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Execute Agreement for $27 Million Funding Transaction for Hope Clinic Acquisition

THOMSON REUTERS
·
28 Jan

Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition

Dow Jones
·
28 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Advances Relationship With Anson Funds With $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt

THOMSON REUTERS
·
28 Jan

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt

PR Newswire
·
28 Jan

NRX Pharmaceuticals, Inc. (Nasdaq: Nrxp) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

THOMSON REUTERS
·
21 Jan

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

PR Newswire
·
21 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces the Appointment of Michael Taylor to Its Board of Directors and Appointment of Anita Nunes as Board Observer; MS. Nunes to Be Appointed Director of Hope Therapeutics, Inc.

THOMSON REUTERS
·
15 Jan

Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces the Appointment of Michael Taylor to its Board of Directors and Appointment of Anita Nunes as Board Observer; Ms. Nunes to be Appointed Director of HOPE Therapeutics, Inc.

Dow Jones
·
15 Jan

Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

Dow Jones
·
14 Jan

NRx Pharmaceuticals files to uplist securities to Nasdaq Global Market

TIPRANKS
·
13 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces It Has Filed an Application With Nasdaq to Uplist to the Nasdaq Global Market From the Nasdaq Capital Market

THOMSON REUTERS
·
13 Jan

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market

PR Newswire
·
13 Jan

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club

PR Newswire
·
10 Jan

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco

PR Newswire
·
07 Jan

NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk

Dow Jones
·
07 Jan

BRIEF-Hope Therapeutics™, Inc. And Nrx Pharmaceuticals, Inc.Announce Signing Of Binding Term Sheet For $27 Million In Funding For Hope Clinic Acquisitions And Pharmaceutical Operations

Reuters
·
07 Jan

NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding

TIPRANKS
·
06 Jan

NRX Pharmaceuticals Inc: Smith & Sauer Will Be Entitled to Receive Royalties on Net REV From NRX Product Sales to a Defined Rate of Return

THOMSON REUTERS
·
06 Jan